基托桑,衍生品及其纳米粒子:制备,物理化学性质,生物活动和生物医学应用 - - 一个全面的综述
Mohamed T El-Saadony1, Ahmed M Saad2, Samar Sami Alkafaas3
1Department of Agricultural Microbiology, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.
International journal of biological macromolecules
|April 5, 2025
概括
基托桑及其纳米颗粒为先进的生物医学用途提供了独特的特性. 它们的生物相容性和药物输送能力显示出对增强治疗和诊断的巨大希望.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
背景情况:
- 基是一种天然基聚合物,因其生物相容性,生物降解性和无毒性而受到重视.
- 它的氨基和基团赋予粘膜粘附,增强透性和抗菌活性.
- 原酸的有限溶解性需要更广泛的应用的化学修饰.
研究的目的:
- 审查基托和基托纳米颗粒的物理化学性质和生物活性.
- 突出其多样化和有前途的生物医学应用.
- 强调其在先进药物输送系统中的潜力.
主要方法:
- 对奇托和奇托纳米粒子研究的文献综述.
- 对物理化学性质和生物活动的分析.
- 检查各种生物医学应用.
主要成果:
- 桑衍生物,特别是纳米粒子,具有更好的溶解性和定制性质.
- 基托桑纳米颗粒作为有效的药物载体,具有受控释放和向的输送功能.
- 在药物输送,疫苗管理,基因疗法和诊断方面展示了显著的潜力.
结论:
- 基托桑及其纳米颗粒具有独特的特性,适用于先进的生物医学应用.
- 这些材料提供了增强的药物有效性和安全性.
- 对基托基系统的进一步研究有望在医疗保健领域取得重大进展.
相关概念视频
DNA Microarrays
16.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
16.8K
Applications Of NMR In Biology
3.3K
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
3.3K
Biopharmaceutics and Pharmacokinetics: Overview
4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
Bioavailability Enhancement: Drug Solubility Enhancement
499
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
499
Bioavailability Enhancement: Drug Permeability Enhancement
352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332


